Evaluation of efficacy of topical Naloxone® in control of neurotic pruritus
Phase 1
- Conditions
- eurodermatitis.Neurotic excoriation
- Registration Number
- IRCT201702231165N18
- Lead Sponsor
- Baqiyatallah University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
The patient has no addiction; have not been treated with any form of topical steroids; diagnosis of neurodermitis has been confirmed by a physician; the content form should have been completed by the patient; age between 25 and 65 years; have no other skin disorders; accessible at all times during the trial; do not leave the treatment after one week; do not have allergy to the medication. Exclusion criteria: when disease become uncontrollable; severe reaction or allergy to the medication; patients’ age less the 25 and more than 65 years
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of itching area. Timepoint: Before intervention; after intervention. Method of measurement: Standard Questionaries.;Distribution of itching area. Timepoint: Before intervention; after intervention. Method of measurement: Standard Questionaries.;Quality of life. Timepoint: Before intervention; after intervention. Method of measurement: Standard questionaries.
- Secondary Outcome Measures
Name Time Method Itching Freqency. Timepoint: Before intervention; After intervention. Method of measurement: Standard Questionaries.